Latest / The Poultry Podcast Show / Dr. Theresia Lavergne: Bacillus & Poultry Performance | Ep. 149
Transcript
- 0:00[SPEAKER_01]: Not all the silice, like I said, are the same.
- 0:02[SPEAKER_01]: So they can have different characteristics.
- 0:06[SPEAKER_01]: One bacillus strain might be better at reducing or improving gut barrier function.
- 0:13[SPEAKER_01]: Another might be better at inhibiting avian pathogenic E coli.
- 0:20[SPEAKER_01]: I have just tended to use a combination of two or three in a together because you kind of get a broader spectrum of what you might control and help to improve the health.
- 0:34[SPEAKER_04]: We want to thank the innovative companies and products who support and trust make this podcast possible.
- 0:41[SPEAKER_02]: Welcome to the Fultry podcast show today.
- 0:43[SPEAKER_02]: I'm here with our guest again, Dr. LeBurn.
- 0:46[SPEAKER_02]: Welcome to the show.
- 0:47[SPEAKER_02]: Hello.
- 0:48[SPEAKER_02]: It's good to be here again.
- 0:50[SPEAKER_02]: I'm so happy that you're able to join again so we can hear more about some different areas of feed added eggs and
- 0:57[SPEAKER_02]: And in the bacillus space, I'm always so interested to hear about some of the recent advancements and what people know about their products are just area that they're working in.
- 1:07[SPEAKER_02]: So can you tell us a little bit about just bacillus in general, what it can do like why you're interested in it.
- 1:14[SPEAKER_01]: Oh, there's that's a lot to answer right there.
- 1:18[SPEAKER_01]: You know, we've gone to where so many of our poultry diets, commercial poultry diets have a bacillus probiotic in them.
- 1:26[SPEAKER_01]: You know, it's probably harder to find diets without bacillus than, you know,
- 1:33[SPEAKER_01]: because they all have it, right?
- 1:34[SPEAKER_01]: We have learned so much that they are not just for pathogen inhibition, which is an excellent trait they have, thank goodness, and we can use them for pathogen inhibition, but there are so many other things that Vasilis do.
- 1:51[SPEAKER_01]: They can produce enzymes.
- 1:54[SPEAKER_01]: our amylase, lipases, lots of different enzymes that can help with nutrient digestibility and improve feed conversion.
- 2:03[SPEAKER_01]: Of course, they can produce antibiotic substances and other metabolites to help prevent infections.
- 2:09[SPEAKER_01]: Whether they're bacteria or fungal, we can prevent infections.
- 2:14[SPEAKER_01]: But as we learn more about these bacillus and, of course, not all the silus strains are the same.
- 2:22[SPEAKER_01]: They're different.
- 2:24[SPEAKER_01]: We've learned that some bacillus will increase expression of tight junction proteins in the gut to help improve gut barrier function, reduce, you know, bleaky gut, help prevent leaky gut and reducing systemic disease.
- 2:41[SPEAKER_01]: We also know that they can help out the immune system.
- 2:46[SPEAKER_01]: We can measure cytokine production or look at the way that bacillus can influence cytokine production.
- 2:53[SPEAKER_01]: Obviously, we would like them to reduce the inflammatory cytokine production.
- 2:58[SPEAKER_01]: And if they can increase the anti-inflammatory cytokine production, that's a great trait as well.
- 3:05[SPEAKER_01]: So we kind of get all of that, you know, preventing leaky gut, maintaining a good gut barrier function, you know, helping overall health improve the improve and working with immune system as well as the pathogen reduction at the same time.
- 3:23[SPEAKER_01]: And then the enzymes there to help improve digestibility of what we're feeding.
- 3:28[SPEAKER_01]: I'm an of course from a nutritionist standpoint.
- 3:30[SPEAKER_01]: That's excellent to know that we can use bacillus for that because it really in the commercial production, you know, the nutritionist is going to have responsibility for putting probiotics into the diet.
- 3:44[SPEAKER_01]: And when they can experience a benefit that can help their cost and improve feed efficiency.
- 3:51[SPEAKER_01]: That's really going to be a benefit to not only the health of the bird, but the nutrition as well.
- 3:57[SPEAKER_02]: Yeah.
- 3:58[SPEAKER_02]: So I know that the different strains have their own specific activity.
- 4:03[SPEAKER_02]: Is it recommended?
- 4:06[SPEAKER_02]: I mean, within a product, my group has found that more complex formulations seem to have a better ability to improve whatever parameter you're looking at, production, mortality, whatever.
- 4:18[SPEAKER_02]: But are these products formulated to put together
- 4:22[SPEAKER_02]: Multiple are they single strain?
- 4:24[SPEAKER_02]: I mean, what's what's kind of your best advice for using them?
- 4:27[SPEAKER_02]: Given the diverse effects is that find one that has an activity that you like or maybe find one that could do a bunch of different things kind of based on a need.
- 4:37[SPEAKER_01]: I think that you know, a lot of times we're using these bacillus for prevention and
- 4:44[SPEAKER_01]: They not all the silice, like I said, are the same.
- 4:47[SPEAKER_01]: So they can have different characteristics.
- 4:51[SPEAKER_01]: One bacillus strain might be better at reducing or improving gut barrier function.
- 4:58[SPEAKER_01]: Another might be better at inhibiting avian pathogenic E coli.
- 5:03[SPEAKER_01]: So it's it's
- 5:05[SPEAKER_01]: I have just tended to use a combination of two or three in a together because you kind of get a broader spectrum of what you might control and help to improve the health.
- 5:17[SPEAKER_01]: Now, there are some bacillus I've worked with that have just kind of been really work horses and maybe could do the job themselves.
- 5:25[SPEAKER_01]: But, you know, I kind of find that probably across the industry in the feed additives were probably
- 5:32[SPEAKER_01]: using more than one bacillus species or strain or isolate whatever in the product.
- 5:40[SPEAKER_01]: Because again, you know, we want to, there's prevention a lot of time, but also to, you know, kind of take care of some problems or challenges that are there.
- 5:49[SPEAKER_01]: So I think we just find that because they have different characteristics, it's great.
- 5:53[SPEAKER_01]: We can use a combination of a few different together in the same formula.
- 5:58[SPEAKER_02]: Yeah, that definitely makes sense.
- 6:01[SPEAKER_02]: So on the evaluation side, it can be really difficult commercially.
- 6:05[SPEAKER_02]: I mean, you have a lot of birds, a lot of bird replicates, if you will, but how do you evaluate the intended effect or efficacy?
- 6:14[SPEAKER_02]: Like, how do we know?
- 6:16[SPEAKER_01]: Sure.
- 6:17[SPEAKER_01]: So that actually starts when you're trying to find the bacillus to go into your products, correct?
- 6:25[SPEAKER_01]: And just as kind of,
- 6:27[SPEAKER_01]: What we do is go into the environment that poultry are in.
- 6:31[SPEAKER_01]: You kind of collect targeted samples that you can isolate bacillus from from environment or even from the intestines of poultry themselves and then you isolate these bacillus that are there and they can go through a whole big screening process and it's
- 6:49[SPEAKER_01]: not probably the first bacillus you isolate, you know, it could take a while, just as an example, in our current product, there were more than a thousand bacillus isolates that started the process and was narrowed down to about six.
- 7:03[SPEAKER_01]: And then we selected two to go in, in these are novel bacillus, selected two to go into our product.
- 7:10[SPEAKER_01]: And in order to do that, you know, we had set, or there had been set a series of criteria that those bacillus had to meet.
- 7:18[SPEAKER_01]: And one of them was to help improve gut barrier function.
- 7:23[SPEAKER_01]: So you go into the lab, a lot of in vitro assays to screen these bacillus to see if they'll have the characteristics we're looking for.
- 7:32[SPEAKER_01]: So to look for gut barrier function improvement, we use an assay called transethithelial electrical resistance or tear.
- 7:42[SPEAKER_01]: Okay, and this, you put, you use a cell line, put the bacillus in with the cell line, and kind of, and then of course, you know, let use the tier to measure your electrical resistance.
- 7:58[SPEAKER_01]: And of course, if there's more resistance,
- 8:00[SPEAKER_01]: that should translate to more or a better gut barrier function.
- 8:05[SPEAKER_01]: Of course, less resistance, you know, letting things through.
- 8:10[SPEAKER_01]: So more compromise get barrier.
- 8:13[SPEAKER_01]: And you can do this with a challenge, maybe with an LPS, lipopolysack right challenge or not.
- 8:22[SPEAKER_01]: And you don't, and this assay is not just for bacillus, we can evaluate different feed additives kind of in the same way with the challenge, maybe a buterate or, you know, just all the bacillus or, you know, just whatever we're looking at, and actually could look at different combinations of feed additives that might go into a diet together, maybe the bacillus and the buterate.
- 8:42[SPEAKER_01]: And do a challenge in this type of assay and look and see how those components might affect a gut barrier function.
- 8:51[SPEAKER_01]: So in the screening process, we can evaluate gut barrier function in vitro like that.
- 8:58[SPEAKER_01]: And then we also want to make sure we're going to do good things with the immune system.
- 9:04[SPEAKER_01]: So again, you know, go back into the in vitro assales and do a challenge again, whatever that is, maybe LPS again, it's pretty common with your cell line and you know, just look to see it the cytokine production.
- 9:19[SPEAKER_01]: Are we increasing anti-inflammatory cytokines?
- 9:23[SPEAKER_01]: Are they decreasing the inflammatory cytokines?
- 9:29[SPEAKER_01]: Those are just a couple of assays there we can do to look at gut barrier function and working with the immune system and use those to kind of predict what should happen in the bird itself.
- 9:44[SPEAKER_01]: And then, of course, we want to go in vivo.
- 9:47[SPEAKER_01]: Once we've screened these bacillus and have positive results in the lab, because that's where we really have to see the result is in the burden, of course.
- 9:57[SPEAKER_01]: And we can do controlled research trials with challenges, see what happens there.
- 10:03[SPEAKER_01]: Of course, we can collect the microbiome out of those birds and use that microbiome in these assays, the TRSA, or
- 10:12[SPEAKER_01]: whatever other challenge we're looking at as well to look at how they're working in the live bird as well.
- 10:19[SPEAKER_01]: And then, you know, the enzyme portion of what the bacillus can do, the enzyme production, of course, then we can evaluate the feed conversion there and protein and energy digestibility in the live bird.
- 10:32[SPEAKER_01]: So it's a long process, detailed process in order to get, but that's what you need to do.
- 10:38[SPEAKER_01]: You want to get what's going to help the industry the most and be the most effective.
- 10:44[SPEAKER_02]: It's got to feel good though that you ended up with some targets at the end of these processes, because that is a ton of work.
- 10:50[SPEAKER_02]: And once that in tears, I'm assuming, from the scientific team.
- 10:55[SPEAKER_01]: Well, we have an excellent partner that we work with.
- 10:59[SPEAKER_01]: And yes, they've spent a lot of time into, you know, locating or finding these bacillus and putting them through the process.
- 11:07[SPEAKER_01]: And it's never ending process just because we have
- 11:11[SPEAKER_01]: Basilis in our current product doesn't mean we're stopping, right?
- 11:14[SPEAKER_01]: The continuous looking for more Basilis that can fit into the program and, you know, be effective in another way or more effective than what we've found so far.
- 11:26[SPEAKER_01]: That's a continuous process.
- 11:27[SPEAKER_01]: It's happening all the time.
- 11:29[SPEAKER_02]: Yes, well, that's exciting.
- 11:30[SPEAKER_02]: You always have something to look forward to and then, you know, the beta version of all your products to roll out.
- 11:37[SPEAKER_02]: So you mentioned that some of the bacillus might have an ability to do pathogen inhibition.
- 11:43[SPEAKER_02]: I know people are really excited about anything foodborne or other poultry passage and related if
- 11:50[SPEAKER_02]: if a probiotic or other bacteria might have that fact.
- 11:54[SPEAKER_02]: So what what have you found so far for these bacillus products that you're working with or others?
- 12:00[SPEAKER_01]: And actually, I think the list of pathogens that we're seeing some inhibition efficacy is growing.
- 12:07[SPEAKER_01]: But I guess traditionally, or maybe I think traditionally, but we've looked at as avian pathogenicicolide and claustridium for friends.
- 12:16[SPEAKER_01]: Now, we're seeing more that might be effective at inhibiting salmonella.
- 12:21[SPEAKER_01]: And really, now, there's quite a bit of work out there looking at anarchoccus decorum as well.
- 12:28[SPEAKER_01]: So, again, and that's why
- 12:32[SPEAKER_01]: not only inhibiting that, like as an example in our caucus accord, inhibition, but also having the bacillus to prevent or leaky gut would be, you know, it could be a huge deal right there and helping to prevent kinky back.
- 12:47[SPEAKER_01]: So you know, so we're looking at pathogen inhibition.
- 12:50[SPEAKER_01]: Those are just some of the pathogens.
- 12:52[SPEAKER_01]: And you know, there's several in vitro assays that you can do that.
- 12:56[SPEAKER_01]: Auger, well diffusion, right?
- 12:57[SPEAKER_01]: You you incubate your bacillus and the auger add the pathogen.
- 13:04[SPEAKER_01]: and look at the zone of inhibition.
- 13:06[SPEAKER_01]: You're measuring those zone of inhibitions on your plates.
- 13:09[SPEAKER_01]: We can also do co-culturing assays, right?
- 13:13[SPEAKER_01]: We grow the bacilla sands, the pathogen together, and do the plating, you know, count.
- 13:21[SPEAKER_01]: The pathogen load to see what we've done to prevent that, which bacillus are doing a better job at preventing or inhibiting the groves of the pathogens.
- 13:33[SPEAKER_01]: And then, of course, I like to go in vivo again.
- 13:37[SPEAKER_01]: And in controlled research trials, we can do some pathogen challenges there, or we can just do the natural pathogens that might be coming from the litter or the environment.
- 13:49[SPEAKER_01]: But we do some field work as well, and we'll, as an example, just kind of before customer goes on product, take some intestinal samples, and look at the pathogen loads, and we call that our baseline.
- 14:03[SPEAKER_01]: And then after three or four flocks might go through the same complex.
- 14:10[SPEAKER_01]: So six months later or so maybe we go back and can collect some more intestinal samples.
- 14:17[SPEAKER_01]: And compare the pathogen load prior to going on a probiotic compared to where they are when we come back.
- 14:23[SPEAKER_01]: look at the pathogen loads and you know just continuously do that you know a couple times a year or however you know we feel that that particular production needs to be monitored.
- 14:36[SPEAKER_01]: So there's you know course lots of way we have all the lab capabilities to measure the pathogen
- 14:41[SPEAKER_01]: pathogens and can the bacillus inhibit those and prevent their growth.
- 14:45[SPEAKER_01]: And then of course we really need to know what it does in the field or in the live bird to make sure it's translating from the lab to live production.
- 14:53[SPEAKER_02]: Yeah, that the process is rigorous.
- 14:56[SPEAKER_02]: It is.
- 14:58[SPEAKER_02]: Not for the pain of heart is what I'm gathering, but it's true for a lot of the answer.
- 15:03[SPEAKER_02]: So when you decide to follow a bacillus strain, you've mentioned a few of the characters that you're interested in, but there might be some that you're looking for and some that you just absolutely don't want.
- 15:16[SPEAKER_02]: I mean, anything that because of problem, obviously you don't want, but what are some of the key things that you are screening for?
- 15:24[SPEAKER_01]: So again, I guess I kind of go back to what I was started talking about, you know, looking for targeted samples to find your basilis.
- 15:33[SPEAKER_01]: Okay, and then of course, you want to put them through some of the assays I mentioned, you know, depending on what characteristics you're looking for.
- 15:41[SPEAKER_01]: So, you know, the isolates.
- 15:45[SPEAKER_01]: Once we obtain the isolates, they can go through tier to look at gut integrity.
- 15:50[SPEAKER_01]: We can do the other challenges to look at their cytokine production.
- 15:54[SPEAKER_01]: And then, of course, we're going to look at the pathogen inhibition as well.
- 15:59[SPEAKER_01]: And so those are functions we want in the bacillus.
- 16:03[SPEAKER_01]: But there are also characteristics that we do not want.
- 16:07[SPEAKER_01]: So a lot of the, or so we do some whole genome sequencing of the bacillus because we want to make sure they themselves do not have any violence factors that they are not pathogenic in any way.
- 16:21[SPEAKER_01]: So we obviously don't want them doing something negative.
- 16:25[SPEAKER_01]: So we kind of, we look for those kind of things.
- 16:28[SPEAKER_01]: We also want to make sure that they're good biomass producers.
- 16:32[SPEAKER_01]: Right, so we can grow them to have enough to put into the feed.
- 16:36[SPEAKER_01]: We also want to make sure that they are they can spoil it.
- 16:41[SPEAKER_01]: Of course, we want our bacillus in the sport form.
- 16:45[SPEAKER_01]: When we put it into the feed, so it can survive our pelleting process to get to the bird.
- 16:53[SPEAKER_01]: We also want to make sure that they're gut stable.
- 16:57[SPEAKER_01]: Look at how effective they are at different levels of acidity, different pH levels.
- 17:03[SPEAKER_01]: Make sure they're going to survive everything that can happen and get to where they need to be most effective.
- 17:10[SPEAKER_01]: So like I said earlier, it's a pretty, it can be a pretty intense process by the time you get through all the in vitro.
- 17:16[SPEAKER_01]: And then like I said, in vivo screening, looking at the characteristics of the bacillus themselves to make sure, like I said, they're not pathogenic or viralent and make sure they'll grow well and exfoliate and get to where they need to be.
- 17:32[SPEAKER_01]: And then of course, we need to do the in vivo.
- 17:35[SPEAKER_01]: work as well.
- 17:37[SPEAKER_01]: Make sure, you know, are we seeing the increase in digestibility, nutrient digestibility that we say we're going to see when we do some in the feature assays, you know, are we seeing the pathogen inhibition?
- 17:53[SPEAKER_01]: Really in live birds because that's again where they have to work.
- 17:58[SPEAKER_02]: So at the very end of this process, you end up with a feeding recommendation, I'm sure based on titration or other studies, do you feel like your feeding recommendations always match with what you find on the scientific side?
- 18:12[SPEAKER_02]: I mean, sometimes I feel like you might have to add a little bit more to get better activity, but it may not be a practical level to feed.
- 18:18[SPEAKER_02]: So how do you balance at the end, what to give the birds?
- 18:22[SPEAKER_01]: So, yes, because if you look across the industry and across the research, you will see a lot of different recommendations, usually in CFUs, commonly forming units per gram.
- 18:32[SPEAKER_01]: You see a lot of recommendations.
- 18:35[SPEAKER_01]: So, the partners that we work with have actually done quite a bit of those titrations.
- 18:41[SPEAKER_01]: research over the years and actually have done some most recently with the specific bacillus and these are bacillus vellisensis that we have in this product that we commercially use.
- 18:55[SPEAKER_01]: And actually, I found it's a pretty low CFU's program that's been very effective.
- 19:02[SPEAKER_01]: The total product, I'll have about a hundred fifty thousand CFU's program.
- 19:06[SPEAKER_01]: But you will see a lot higher load in across all different products and research.
- 19:14[SPEAKER_01]: And yeah, I
- 19:17[SPEAKER_01]: don't know where, you know, all the numbers have come up with.
- 19:20[SPEAKER_01]: I mean, hopefully there's a lot of those titrations, and I guess it can go back to not all the syllables are the same.
- 19:27[SPEAKER_01]: So, yeah, I have no idea where to go with the levels we're seeing in some of these products, and I just don't know their research or their backing behind the loads.
- 19:41[SPEAKER_01]: that they need.
- 19:42[SPEAKER_01]: But we do find that there are times that challenges the level of challenge may require more CFUs for grants.
- 19:51[SPEAKER_01]: You know, maybe it's different phases of growth.
- 19:54[SPEAKER_01]: You know, a lot of times in the starter phase, they just don't need as much food.
- 19:58[SPEAKER_01]: So we might use a higher CFUs there in their diet compared to the finisher when they're eating a lot more total feed.
- 20:07[SPEAKER_01]: And then in the end, kind of it might even out that they're actually consuming the same amount or more similar CFUs program, just based on their rate of feed intake.
- 20:16[SPEAKER_01]: There's a lot of variation out there in the industry is to be inclusion rates.
- 20:22[SPEAKER_02]: Yeah, definitely.
- 20:23[SPEAKER_02]: And from a scientific side, like you said, there might be a reason to change it, but then you got to get the feedback to agree with you and then the producer with the cost.
- 20:31[SPEAKER_01]: So, right, and I find that I guess a lot of them, you know, when we
- 20:36[SPEAKER_01]: at the carriers, right?
- 20:37[SPEAKER_01]: We're somewhere between a half a pound to a one pound per ton of, you know, inclusion, right?
- 20:44[SPEAKER_01]: And you know, I obviously can vary based on what a mill needs and what they're capable of using.
- 20:50[SPEAKER_01]: So we can alter the CFUs program.
- 20:53[SPEAKER_01]: Oh, sure.
- 20:54[SPEAKER_01]: And they'll still have the same half a pound or one pound inclusion rate at the mill, which is good.
- 20:58[SPEAKER_01]: Yeah.
- 20:58[SPEAKER_01]: They're perfect.
- 21:00[SPEAKER_01]: Make things a little easier for the mill and the nutritionists.
- 21:05[SPEAKER_04]: It's time for our famous three.
- 21:09[SPEAKER_04]: We want to thank the innovative companies and products who support and trust make this podcast possible.
- 21:15[SPEAKER_02]: Yeah, definitely.
- 21:16[SPEAKER_02]: Is there anything about bacillus or choosing or the research that you wanted to highlight or that we missed during our chat today?
- 21:25[SPEAKER_01]: I think it's just emphasizing things we've said, you know, bacillus can do more and do do more than just pathogen inhibition, pathogen inhibition is very important.
- 21:37[SPEAKER_01]: But there are other characteristics.
- 21:40[SPEAKER_01]: And this is not a complete list.
- 21:42[SPEAKER_01]: You know, what I've talked about, you know, got barrier function and working with the immune system in enzymes.
- 21:51[SPEAKER_01]: You know, that's not a complete list.
- 21:52[SPEAKER_01]: And thank goodness we like to learn.
- 21:55[SPEAKER_01]: So we're learning more all the time about bacillus.
- 21:58[SPEAKER_01]: And, you know, they're very abundant.
- 22:00[SPEAKER_01]: We were finding more.
- 22:03[SPEAKER_01]: looking for some that might be more effective and have other characteristics that we can combine with what we're currently using to be even more effective.
- 22:13[SPEAKER_01]: So it's just an endless, like most things, an endless science that we're putting into our feet and to improve the health of birds and it's just, and then I guess at the same time you have to make sure they're not going to do any harm.
- 22:26[SPEAKER_01]: So that's why we have to screen them for bad characteristics as well, which in all and all, it's all very important that we screen good and bad to do what's best to help out the industry the most.
- 22:39[SPEAKER_02]: Well, so I know you're talking about this illness in animals, but just to wrap up, do you have a favor from my outfit that you take just because you're in the area?
- 22:46[SPEAKER_02]: I feel like you'd be all over that.
- 22:48[SPEAKER_02]: Like yoga, maybe.
- 22:52[SPEAKER_01]: I do mean yoga at almost every day.
- 22:54[SPEAKER_01]: Yeah.
- 22:56[SPEAKER_01]: But no, I don't have a specific one.
- 23:03[SPEAKER_01]: And that's kind of maybe it's my thinking because in poultry, we can be so targeted at the pathogens where trying to control that I feel like, yeah, there's ways to do that in humans.
- 23:17[SPEAKER_01]: But I just feel like I'm just going to go, I just kind of buy one.
- 23:22[SPEAKER_01]: Yeah.
- 23:22[SPEAKER_01]: I do take them.
- 23:23[SPEAKER_01]: I do take them.
- 23:24[SPEAKER_01]: But I, you know, just feel like, oh, we can't get a specific in humans.
- 23:28[SPEAKER_01]: And I guess we can.
- 23:29[SPEAKER_01]: For the most part, no, we're not going to collect our intestines.
- 23:32[SPEAKER_01]: And so we have other ways to look at our microbiome and what's in it.
- 23:37[SPEAKER_01]: But you know, the microbiome varies so much between people and households.
- 23:44[SPEAKER_01]: And you know, I just, you know, it's like,
- 23:46[SPEAKER_01]: Yeah.
- 23:47[SPEAKER_01]: There are cases where they can make a specific probiotic for somebody based on, you know, a disease or, you know, what their microbiome needs, but I'm not there.
- 23:57[SPEAKER_01]: I think I'm good and I can just buy one off the shelf.
- 24:02[SPEAKER_01]: But it's, yeah, it's a whole different, I think, a whole different product in humans versus animals because we can be so much more targeted across, you know, complex.
- 24:15[SPEAKER_01]: of, you know, a broiler complex or turkey complex where, yeah, humans, not so much.
- 24:21[SPEAKER_01]: Why have you asked?
- 24:23[SPEAKER_01]: Yes.
- 24:24[SPEAKER_02]: I honestly thought looking in this story online that I know more about potential poultry products and probiotics than I do about the ones that humans might take.
- 24:34[SPEAKER_02]: So it kind of makes you back off for a second because I really like to information seek.
- 24:40[SPEAKER_01]: You know, yeah, but it's still good to get that good bacteria and our good as well.
- 24:45[SPEAKER_02]: Well, thank you so much for chatting again today.
- 24:48[SPEAKER_02]: This is always so informational and I love hearing updates and things that are going on within the industry.
- 24:53[SPEAKER_02]: So thank you.
- 24:54[SPEAKER_00]: Oh, you're welcome.
- 24:55[SPEAKER_00]: It's very good to get to chat and talk about our passions.
- 24:59[SPEAKER_02]: I agree with those of you guys listening.
- 25:01[SPEAKER_02]: Like and share the episode because we'd like more people to hear about our great topics that we chat about.
- 25:06[SPEAKER_02]: Thank you.
- 25:08[SPEAKER_03]: Do you feel overwhelmed with mundane tasks that eat up your valuable time?
- 25:12[SPEAKER_03]: It's time to reclaim your schedule and focus on what truly matters.
- 25:15[SPEAKER_03]: Get your time back with elite remote talent without a time zone hassle.
- 25:19[SPEAKER_03]: Delegate ten dollar an hour tasks to focus on more thousand dollar an hour tasks.
- 25:23[SPEAKER_03]: Schedule your free strategy call at yzvas.io.